Nachrichten zur Bio Techne Corp. Aktie

BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES

MINNEAPOLIS, Aug. 28, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor…

BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST

MINNEAPOLIS, Aug. 24, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host its 2023 Investor Day…

Form 10-K BIO-TECHNE Corp For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023

MINNEAPOLIS, Aug. 15, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief…

Bio-Techne misses revenue estimates on biotech funding crunch

...Aug 8 (Reuters) - Bio-Techne Corp reported fourth-quarter revenue......…

Bio-Techne Non-GAAP EPS of $0.55 in-line, revenue of $301.32M misses by $6.96M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K BIO-TECHNE Corp For: Aug 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

BIO-TECHNE DECLARES DIVIDEND

MINNEAPOLIS, Aug. 8, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay…

BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS

MINNEAPOLIS, Aug. 8, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended…

Bio-Techne Q4 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Executive Officer verkauft Aktien von Bio-Techne im Wert von 7.069.024$

Kummeth, Charles R. - Vorstand - Tag der Transaktion: 2023-07-21...…

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS

MINNEAPOLIS, July 13, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and…

BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION

MINNEAPOLIS, July 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced it has completed the acquisition of Lunaphore Technologies SA,…

BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE

MINNEAPOLIS, May 25, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief…

BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE

MINNEAPOLIS, May 12, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief…

Form 10-Q BIO-TECHNE Corp For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bio-Techne declares $0.08 dividend

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bio-Techne: Q3 Earnings Insights

BIO-TECHNE DECLARES DIVIDEND

MINNEAPOLIS, May 3, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay…

Form 8-K BIO-TECHNE Corp For: May 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS

MINNEAPOLIS, May 3, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended…

Bio-Techne Q3 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS

MINNEAPOLIS, April 12, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and…

BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING

MINNEAPOLIS, April 3, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its investment in Wilson Wolf…

BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE

MINNEAPOLIS, March 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief…

Form 8-K BIO-TECHNE Corp For: Feb 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF

MINNEAPOLIS, March 1, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced Wilson Wolf Manufacturing has met the trailing 12-month earnings…

BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE

MINNEAPOLIS, Feb. 28, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer,…

BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE

MINNEAPOLIS, Feb. 22, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief…

BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES

MINNEAPOLIS, Feb. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cell Signaling Technology (CST) announced today the addition of…

XFRA : DIVIDEND/INTEREST INFORMATION - 10.02.2023 - US09073M1045

Das Instrument TE1 US09073M1045 BIO-TECHNE CORP. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 10.02.2023 The instrument TE1 US09073M1045 BIO-TECHNE…

Bio-Techne declares $0.08 dividend

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BIO-TECHNE DECLARES DIVIDEND

MINNEAPOLIS, Feb. 2, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay…

Bio-Techne GAAP EPS of $0.31 misses by $0.03, revenue of $271.58M misses by $18.15M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bio-Techne Q2 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BIO-TECHNE LAUNCHES THE MauriceFlex™ SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS

MINNEAPOLIS, Jan. 26, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of its ProteinSimple-branded MauriceFlex™ during the…

BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS

MINNEAPOLIS, Jan. 17, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and…

Agilent, Bio-Techne upgraded as Wells Fargo revises life sciences outlook

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

MINNEAPOLIS, Dec. 21, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer,…

Lateral flow assay components market to grow by 4.41% Y-O-Y from 2023 to 2027: Rising efforts in research and development will drive growth -Technavio

NEW YORK, Dec. 16, 2022 /PRNewswire/ -- Lateral flow assay components market insights - Vendors: 15+, Including Abbott Laboratories, Ahlstrom…

Insiderhandel: SVP - GENERAL COUNSEL verkauft Aktien von Bio-Techne im Wert von 611.810$

Furlow, Brenda S. - Vorstand - Tag der Transaktion: 2022-12-08...…

Insiderhandel: SVP - GENERAL COUNSEL verkauft Aktien von Bio-Techne im Wert von 65.605$

Furlow, Brenda S. - Vorstand - Tag der Transaktion: 2022-12-07...…

BIO-TECHNE RELEASES MITOBRILLIANT™ FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS

MINNEAPOLIS, Dec. 5, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the introduction of MitoBrilliant™ probes. These novel probes…

dpa-AFX ProFeed